Liberty appears to be making steady progress in Florida. Arcview Marketing Research and BDS Analytics project the state's medical cannabis market will top $1.7 billion by 2022 . Liberty Health Sciences thinks it currently declares a 15% market share. With brand-new dispensaries and significantly higher production capacity on the way, the company could improve that share significantly.
I think that all the company needs to do is persevere with its efforts in Florida and Ohio to be worth a lot more over the next couple of years. .
Mr. George Scorsis has more than 15 years of experience leading companies in extremely regulated markets to rapid growth, consisting of alcohol, energy drinks and, most just recently, medical cannabis. Formerly CEO of Liberty Health Sciences, Mr. Scorsis leveraged his comprehensive background in handling development within a highly managed environment to broaden Liberty Health Sciences Inc.'s cannabis-related platforms in the United States.
Scorsis was President of Red Bull Canada where he contributed in reorganizing the organization from a geographical and operational perspective, growing the service to $150 MM in profits. He also worked carefully with Health Canada on guidelines regulating the energy drink category while likewise establishing a corporately owned circulation model in volatile markets.
Scorsis added to the company becoming an industry leader and ultimately seeing the company sell for $ 430 MM. He likewise functioned as Chairman of the Board of Directors of Scythian Biosciences Corp., a research and development company committed to advancing treatment efforts for distressing brain injury with its proprietary cannabinoid-based combination drug treatment and extra cannabis-related activities throughout the world.
The pending legalization of leisure cannabis in Canada might be attracting all the attention nowadays, but for Liberty Health Sciences Inc. president George Scorsis, it's the opportunities that lie south of the border that are all-consuming. Florida-based Liberty, which till this month counted cannabis giant Aphria among its biggest shareholders, has been building a grip in a rapidly growing U.S
. But it's the potential to ultimately pivot into other sectors, from health and wellness to the adult-use market, ought to the latter ever be legislated federally in the U.S., that might be the most tantalizing."( Health and wellness) is the segment in which we need to manage the supply chain before it goes mainstream," states Scorsis, a previous president of Red Bull Canada who now splits his time in between Canada and Florida.
My task is to commercialize businesses." Amongst the pending advancements that might accelerate that process for Liberty are proposed modifications to U.S. hemp laws. The U.S. Hemp Farming Act of 2018, a proposed law to get rid of hemp from Schedule I controlled compounds, got Senate approval in early July and could be passed as early as this fall.
federal cannabis laws are reformed," Aphria CEO Vic Neufeld said in a release on Thursday. "We anticipate viewing our tactical partner Liberty continue to perform on the many chances emerging today." In the meantime, Scorsis is bullish on Liberty's position in the medical marijuana space, where he notes they own "growing, distribution and sale." The LP is headquartered in Gainesville-- where it has greenhouses in addition to processing facilities and dispensaries-- and anticipates its production capacity will be roughly 14,600 kilograms yearly by early next year.